Transgene SA (EPA:TNG)
France · Delayed Price · Currency is EUR 1.105
-0.020 (-1.78%)
Sep 4, 2025, 3:38 PM CET
Transgene Market Cap
Transgene has a market cap or net worth of €148.92 million as of September 4, 2025. Its market cap has increased by 6.85% in one year.
Market Cap
148.92M
Enterprise Value
142.65M
Revenue
6.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.11
Market Cap Chart
Since March 30, 1998, Transgene's market cap has decreased from 151.86M to 148.92M, a decrease of -1.93%. That is a compound annual growth rate of -0.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2025 | 148.92M | 65.92% |
| Dec 31, 2024 | 89.75M | -34.86% |
| Dec 29, 2023 | 137.78M | -16.38% |
| Dec 30, 2022 | 164.76M | -33.52% |
| Dec 31, 2021 | 247.84M | 79.73% |
| Dec 31, 2020 | 137.90M | 6.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 118.56B |
| Sanofi | 103.06B |
| Sartorius Stedim Biotech | 16.79B |
| bioMérieux | 13.66B |
| Eurofins Scientific SE | 10.91B |
| Ipsen | 9.53B |
| ABIVAX Société Anonyme | 5.21B |
| Virbac | 2.74B |